Ashok Subramanian
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging
- Oncology
- Pediatrics, Perinatology and Child Health
- Pulmonary and Respiratory Medicine
- Topics
- Growth Hormone and Insulin-like Growth Factors (7 papers)Cancer Risks and Factors (3 papers)Breast Cancer Treatment Studies (3 papers)
- Cited by
- Radiology, Nuclear Medicine and ImagingPediatrics, Perinatology and Child HealthCancer Research
- Partner nations
- United KingdomUnited StatesChina
In The Last Decade
Ashok Subramanian
17 papers receiving 315 citations
Peers
Comparison fields: 5 of 67
- Molecular Biology 94
- Radiology, Nuclear Medicine and Imaging 91
- Oncology 76
- Pediatrics, Perinatology and Child Health 75
- Pulmonary and Respiratory Medicine 63
Countries citing papers authored by Ashok Subramanian
This map shows the geographic impact of Ashok Subramanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashok Subramanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashok Subramanian more than expected).
Fields of papers citing papers by Ashok Subramanian
This network shows the impact of papers produced by Ashok Subramanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashok Subramanian. The network helps show where Ashok Subramanian may publish in the future.
Co-authorship network of co-authors of Ashok Subramanian
This figure shows the co-authorship network connecting the top 25 collaborators of Ashok Subramanian. A scholar is included among the top collaborators of Ashok Subramanian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashok Subramanian. Ashok Subramanian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 24 | |
| 6 | 1 | |
| 7 | 7 | |
| 8 | Measuring IGF-1, ER-α and EGFR expression can predict tamoxifen-resistance in ER-positive breast cancer. | 23 |
| 9 | 12 | |
| 10 | 32 | |
| 11 | 6 | |
| 12 | 70 | |
| 13 | 1 | |
| 14 | 14 | |
| 15 | 1 | |
| 16 | The potential clinical applications of insulin-like growth factor-1 ligand in human breast cancer. | 12 |
| 17 | Evidence for a tumour suppressive function of IGF1-binding proteins in human breast cancer. | 17 |
| 18 | 93 | |
| 19 | The importance of donor protection by furosemide and steroids in cadaveric kidney preservation. | 1 |
About Ashok Subramanian
Ashok Subramanian is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Oncology, having authored 19 papers that have together received 322 indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (7 papers), Cancer Risks and Factors (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (91 citations), Pediatrics, Perinatology and Child Health (75 citations) and Cancer Research (57 citations). Ashok Subramanian has collaborated with scholars based in United Kingdom, United States and China. Frequent co-authors include Kefah Mokbel, Mohamed Salhab, Anup Sharma, J Baer, David Frager, Chester J. Kay, B Bashist, K Chong, Wen G. Jiang and Robert E. Mansel. Their work appears in journals such as Radiology, Molecular Cancer and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.